Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБУ Санкт-Петербургский научно-исследовательский психоневрологический институт им. В.М.Бехтерева. 192019, Россия, Санкт-Петербург, ул. Бехтерева, д. 3; Санкт-Петербургский государственный университет. 199034, Россия, Санкт-Петербург, Университетская наб., д. 7–9
Список исп. литературыСкрыть список 1. Гомазков О.А. Старение мозга и нейротрофическая терапия. М.: ИКАР, 2011. / Gomazkov O.A. Starenie mozga i neirotroficheskaia terapiia. M.: IKAR, 2011. [in Russian] 2. Addington D, Addington J, Schissel BA. Calgary depression scale for schizophrenia. Schizophr Res 1990; 3: 247–51. 3. Aydemir O, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiat 2005; 29: 261−5. 4. Brito V, Beyer C, Kuppers E. BDNF-dependent stimulation of dopamine D5-receptor expression in developing striatal astrocytes involves PI3-kinase signaling. Glia 2004; 46 (3): 284–95. 5. Castle D, Sham P, Murray R. Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res 1998; 33: 179–83. 6. Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004; 5: 11−25. 7. Dwivedi Y, Rizavi HS, Conley RR et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiat 2003; 60: 804−15. 8. Favalli G, Li J, Belmonte de Abreu P et al. The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiat Research 2012; 46: 1–11. 9. Fumagalli F, Bedogni F, Perez J et al. Corticostriatal brainderived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neuro Sci 2004; 20: 348–54. 10. Gama CS, Andreazza AC, Kunz M. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neuroscience Letters 2007; 420 (1): 45–8. 11. Gervasoni N, Aubry JM, Bondolfi G et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode, Neuropsychobiol 2005; 51 (4): 234–8. 12. Gonul AS, Akdeniz F, Taneli F et al. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiat Clin Neurosci 2005; 255: 381−6. 13. Green MJ, Matheson SL, Shepherd A et al. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiat 2011; 16 (9): 960–72. 14. Hambrecht M, Maurer K. Gender differences in schizophrenia in three cultures. Results of the WHO collaborative study on psychiatric disability. Soc Psychiat Epid 1992; 27: 117–21. 15. Hauger RL, Risbrough V, Oakley RH et al. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann NY Acad Sci 2009; 1179: 120–43. 16. Höglinger GU, Sautter J, Meyer M et al. Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function. Brain Research 1998; 813 (2): 313–22. 17. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Ann Rev Neuroscience 2001; 24: 677–736. 18. Huang TL, Lee CT. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiat Research 2006; 40 (7): 664–8. 19. Hunt IM, Kapur N, Robinson J et al. National confidential inquiry into suicide and homicide by people with mental illness. J Psychiat Pract 2006; 12 (3): 139–47. 20. Issa G et al. An inverse relationship between cortisol and BDNF levels in schizophrenia: Data from human postmortem and animal studies. Neurobiol Disease 2010; 39: 327–33. 21. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neuroscience Letters 2002; 328 (3): 261–4. 22. Karege F, Bondolfi G, Gervasoni N et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiat 2005; 57: 1068−72. 23. Karege F, Perret G, Bondolfi G et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiat Res 2002; 109: 143−8. 24. Kerr B, Kuzhikandathil EV. Brain-derived neurotrophic factor regulates the expression of D1-dopamine receptors. J Neurochemist 2007; 100 (2): 416–28. 25. Koster A, Lajer M, Lindhardt A, Rosenbaum B. Gender differences in first episode psychosis. Soc Psychiat Epid 2008; 43: 940–6. 26. Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Therapeutics 2008; 117: 30–51. 27. Kulkarni J, Castella de A, Fitzgerald PB et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiat 2008; 65: 955–60. 28. Lewin GR, Barde YA. Physiology of the neurotrophins. Ann Rev Neuroscience 1996; 19: 289–317. 29. Maisonpierre PC, Belluscio L, Friedman B et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 1990; 5 (4): 501–9. 30. Matthias J Müller. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: Psychometric properties and reference values. J Affect Dis 2005; 88: 69–74. 31. McEwen BS. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008; 583: 174–85. 32. Noto CS et al. Association of biomarkers and depressive symptoms in schizophrenia. Neuroscience Letters 2011; 505: 282–5. 33. Pan W, Banks WA, Fasold MB et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacol 1998; 37 (12): 1553–61. 34. Reis HJ, Nicolato R, Barbosa IG et al. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neuroscience Letters 2008; 439 (2): 157–9. 35. Riecher-Rossler A, Loffler W, Munk-Jorgensen P. What do we really know about late-onset schizophrenia? Eur Arch Psychiat Clin Neurosci 1997; 247: 195–208. 36. Sauer H, Fischer W, Nikkhah G et al. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Research 1993; 626 (1–2): 37–44. 37. Seeman MV. Interaction of sex, age, and neuroleptic dose. Compr Psychiat 1983; 24: 125–8. 38. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990; 16: 185–94. 39. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiat 2003; 160: 1516−8. 40. Shimizu E, Hashimoto K, Watanabe H et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neuroscience Letters 2003; 351 (2): 111–4. 41. Shimizu E, Hashimoto K, Okamura N et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiat 2003; 54: 70−5. 42. Smith MA, Makino S, Kvetnanský R, Post RM. Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci 1995; 771: 234–9. 43. Spenger C, Hyman C, Studer L et al. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Experim Neurol 1995; 133 (1): 50–63. 44. Spina MB, Squinto SP, Miller J et al. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochemistry 1992; 59 (1): 99–106. 45. Ueyama T, Kawai Y, Nemoto K et al. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 1997; 28: 103–10. 46. Wuet YC et al. Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience 2013; 239: 67–83. 47. Zai CC, Tiwari AK, Luca de V et al. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Europ Neuropsychopharmacol 2009; 19 (5): 317–28.